Evidence map›Paper›PMID 37501262›Full record

ArticleJournal of the International AIDS Society2023

Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies.

Vita W Jongen, Thijs Reyniers, Maarten Schim van der Loeff, Tom Smekens, Elske Hoornenborg, Mark van den Elshout, Hanne Zimmermann, Liza Coyer, Chris Kenyon, Irith De Baetselier and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Vita W JongenDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-9538-1501
Thijs ReyniersDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Maarten Schim van der LoeffDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Tom SmekensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Elske HoornenborgDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0512-2109
Mark van den ElshoutDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0881-5680
Hanne ZimmermannDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1647-8485
Liza CoyerDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-5830-2982
Chris KenyonDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Irith De BaetselierDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-1804-252X
Udi DavidovichDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Henry J C de VriesDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Maria PrinsDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Marie LagaDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Bea VuylstekeDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-0514-4372
Anders BoydDepartment of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands.
GGD Amsterdam · NLInstituut voor Tropische Geneeskunde · BEMaastricht University · NLStichting HIV Monitoring · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDaily and event-driven oral pre-exposure prophylaxis (PrEP) reduce the risk of HIV acquisition. PrEP use can vary over time, yet little is known about the trajectories of PrEP use irrespective of the chosen PrEP regimens among men who have sex with men (MSM).

methodsUsing data from a mobile, web-based diary application collected daily from 17 August 2015 until 6 May 2018, we analysed PrEP use and sexual behaviour in two large cohorts, AMPrEP (Amsterdam, the Netherlands) and Be-PrEP-ared (Antwerp, Belgium). In both cohorts, participants could choose between daily and event-driven oral PrEP every 3 months. We used group-based trajectory modelling to identify trajectories of PrEP use over time and their determinants. In addition, we estimated the incidence rate of chlamydia, gonorrhoea and syphilis within these trajectories.

resultsWe included 516 MSM (n = 322 AMPrEP; n = 194 Be-PrEP-ared), of whom 24% chose event-driven PrEP at PrEP initiation. Participants contributed 225,015 days of follow-up (median = 508 days [IQR = 429-511]). Four distinct PrEP use trajectories were identified: ≤2 tablets per week ("low frequency," 12% of the total population), 4 tablets per week ("variable," 17%), "almost daily" (31%) and "always daily" (41%). Compared to participants with "low frequency" PrEP use, participants with "variable" (odds ratio [OR] = 2.18, 95% confidence interval [CI] = 1.04-4.60) and "almost daily" PrEP use were more often AMPrEP participants (OR = 2.64, 95% CI = 1.27-5.49). "Almost daily" PrEP users were more often employed (OR = 6.76, 95% CI = 2.10-21.75) and were younger compared to participants with "low frequency" PrEP use. In addition, the number of days on which anal sex occurred was lower among participants with "low frequency" PrEP use compared to the other groups (all p<0.001). Compared to "low frequency" PrEP users, the incidence rates of chlamydia and gonorrhoea were higher for participants with "almost daily" and "always daily" PrEP use.

conclusionsWe uncovered four distinct PrEP use trajectories, pointing to different patterns of PrEP use in practice beyond the two-regimen dichotomy. These trajectories were related to sexual behaviour and rates of sexually transmitted infection. Tailoring PrEP care according to different PrEP use patterns could be an important strategy to improve efficient PrEP delivery.

Indexed as

Anti-HIV AgentsGonorrheaHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesHomosexuality, MaleHumansMaleObservational Studies as TopicProspective StudiesSexual BehaviorAnti-HIV Agentscohort studiesEuropeHIV prevention and controlmen who have sex with menpre-exposure prophylaxispublic health

Identifiers

PMID37501262
PMCPMC10374882
OpenAlexW4385330838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.